Radiosurgery in the initial management of malignant gliomas: Survival comparison with the RTOG recursive partitioning analysis

International Journal of Radiation Oncology, Biology, Physics

Volumn 32, Issue 4, 1995, Pages 931-941

  Sarkaria, Jann N ^a   Mehta, Minesh P ^e   Loeffler, Jay S ^b   Buatti, John M ^d   Chappell, Richard J ^a   Levin, Allan B ^a   Alexander III, Eben ^c   Friedman, William A ^b   Kinsella, Timothy J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e Department of Neurosurgery Harvard Medical School ^*

Author keywords

Anaplastic astrocytoma; External beam radiotherapy; Glioblastoma multiforme; Prognostic factors; Stereotactic radiosurgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETANIDAZOLE; LOMUSTINE; PROCARBAZINE; RADIOSENSITIZING AGENT; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; FEMALE; GLIOBLASTOMA; HEMIPARESIS; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION NECROSIS; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; STEREOTAXIC SURGERY; TREATMENT FAILURE; TUMOR VOLUME;

BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; RADIOSURGERY; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0029092253     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)00621-Q     Document Type: Article

References (43)

1. Radiosurgery for gliomas
2. CT prognostic criteria of survival after malignant glioma surgery
3. Cancer statistics
4. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas
5. The role of radiosurgery in the treatment of malignant brain tumors
6. Stereotactic radiosurgery utilizing a linear accelerator
7. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
8. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma
9. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02
10. The role of stereotactic radiosurgery in the treatment of glial tumors
11. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
12. Selection bias, survival, and brachytherapy for glioma
13. Linear accelerator radiosurgery at the University of Florida
14. Increasing radiation dose intensity using hyperfraction in patients with malignant glioma
15. A three-dimensional volume visualization package applied to stereotactic radiosurgery treatment planning
16. A randomized trial of interstitial radiotherapy boost for newly diagnosed malignant glioma: Brain Tumor Cooperative Group Trial 8701
17. External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG 6G-82-2
18. Stereotactic LINAC radiosurgery
19. Assumptions in the radiotherapy of glioblastoma
20. Treatment planning for stereotactic radiosurgery of intra-cranial lesions
21. Monte Carlo and convolution dosimetry for stereotactic radiosurgery
22. Stereotactic radiosurgery using a linear accelerator
23. Fractionated stereotactic radiation for glioma
24. Phase III comparison of BCNU and the combination of procarbazine CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas
25. Radiosurgery as part of the initial management of patients with malignant gliomas
26. Results of stereotatic brachytherapy used in the initial management of patients with glioblastoma
27. A system for stereotactic radiosurgery with a linear accelerator
28. Physical aspects of stereotactic radiotherapy using a linear accelerator
29. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the Radiation Therapy Oncology Group protocol 8302
30. Combined modality approach to treatment of malignant gliomas—Reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group
31. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study
32. Stereotactic radiosurgy in the treatment of patients with malignant CNS tumors
33. Radiosurgery for primary malignant brain tumors
34. Fractionated stereotactic radiation therapy for intracranial tumors
35. Epidemiology of brain tumors: The national survey of intracranial neoplasms
36. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
37. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
38. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
39. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas
40. The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group